PZ18753b

N/A

Report date: 2023/03/02 16:29:25
NME

Base Information

Drug NamePZ18753b
Drug Alias NamePZ-18753bPZ18753b
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionApoptosis regulator Bcl-2 degradersApoptosis regulator Bcl-X degraders
TargetsApoptosis regulator Bcl-2Apoptosis regulator Bcl-X
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of FloridaThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of FloridaThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesN/A
Active IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A